Are there any differences in guideline adherence to pharmacotherapy of heart failure between individual GP practices and Medical Care Centres (MCCs)?;Leitliniengerechte Pharmakotherapie bei herzinsuffizienten Patienten - Gibt es Unterschiede der Behandlung durch Hausärzte in Einzelpraxen und in Medizinischen Versorgungszentren?

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen

Volumn 104, Issue 2, 2010, Pages 113-119

  Dini, Lorena ^a   Heintze, Christoph ^a   Welke, Justus ^a   Stein, Tanja ^a   Rufer, Veronika ^a   Braun, Vittoria ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic heart failure; GP; Guideline implementation; Medical care centre; Pharmacotherapy

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT;

AGED; AMBULATORY CARE; ARTICLE; DIASTOLE; DRUG EFFECT; DRUG THERAPY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; GENERAL PRACTICE; GERMANY; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; STANDARD; STATISTICS; SYSTOLE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALDOSTERONE ANTAGONISTS; AMBULATORY CARE; AMBULATORY CARE FACILITIES; BERLIN; DIASTOLE; DIURETICS; DRUG THERAPY; ECHOCARDIOGRAPHY; FAMILY PRACTICE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SYSTOLE;

EID: 77952292659     PISSN: 18659217     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.zefq.2009.11.001     Document Type: Article

References (21)

1. Statistisches Bundesamt. Gesundheitsberichterstattung des Bundes (http://www. gbe-bund.de/ - letzter Zugriff: Dezember 2007).
2. Senni, et al. Congestive heart failure in the community. Trends in incidence and survival in a 10-Year-period. Arch Intern Med 1999; 159: 29-34.
3. Bungard, et al. Underutilisation of ACE inhibitors in patients with congestive heart failure. Drugs 2001; 61: 2021-2033 (Pubitemid 33135181)
4. Ollenschläger, et al. Medizinische Leitlinien in Deutschland, 1994 bis 2004. Von der Leitlinienmethodik zur Leitlinienimplementierung. Z ärztl Fortbild Qual Gesundh wes 2005; 99: 7-13.
5. Phillips, et al. Barriers to diagnosing and managing heart failure in primary care. MJA 2004; 181: 78-81. (Pubitemid 39069568)
6. Cleland, et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002; 360: 1631-1639
7. Muth, et al. Deutsche Gesellschaft für All-gemeinmedizin und Familienmedizin. Leitlinie IX: Herzinsuffizienz. Omikron Publishing; 2006.
8. Hall, et al. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy. Lancet 1997; 349: 1493-1497
9. Hoppe UC. (2007). Leitliniengerechte Therapie der chronischen Herzinsuffizienz. Der Internist 9/2007. DOI:10.1007/s00108-007-1898-6.
10. Lechat, et al. Clinical effects of betaadrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebocontrolled, randomized trials. Circulation 1998; 8: 1184-1191
11. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MeritHF). Lancet 1999; 353: 2001-2007.
12. Dietz, et al. Behandlung der Herzinsuffizienz: Wunsch und Wirklichkeit zu Beginn des 21. Jahrhunderts. Z ärztl Fortbild Qual sich (ZaeFQ) 2003; 97: 98-103.
13. Pitt, et al. For the prospective randomised Aldactone survival evaluation study investigators. The effects of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717
14. Tschöpe et al. (2009). Heart Failure with Normal Ejection Fraction. Pathophysiologie, Diagnosis and Treatment. Herz 34 2009 Nr. 2. DOI: 10.1007/s00059-009-3197-6.
15. Hobbs, et al. The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice. Eur J Heart Fail 2005; 7: 768-779
16. Jimeno Sainz, et al. Validity of Framingham criteria as a clinical test for systolic heart failure. Rev Clin Esp 2006, 206 (10): 495-498 (Pubitemid 44873328)
17. Flesch, et al. Leitliniengerechte Herzinsuffizienzbehandlung in Deutschland. Ergebnisse der MAHLER-Studie. Dtsch Med Wochenschr 2005; 130: 2191-2197
18. Gemeinsamer Bundesausschuss (2008). Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses zur Richtlinie Ambulante Behandlung im Krankenhaus nach § 116b des Fünften Sozial-gesetzbuch (SGB V): Konkretisierung der spezialisierten Diagnostik und Therapie der schweren Herzinsuffizienz (Stadium NYHA 3-4) in der Anlage 3 Nr. 4 der Richtlinie. BAnz. Nr. 140 (S. 3366) vom 16.09.2008.
19. Peters-Klimm, et al. Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clin Res Cardiol 2008; 97: 244-252
20. de Groote, et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail 2007; 9: 1205-1211 (Pubitemid 350153640)
21. Porta M. A Dictionary of Epidemiology. Oxfrord Univeresity Press; 2008.